Complete response to treatment with hepatic arterial infusion of cisplatin powder (IA-call®) in a case of hepatocellular carcinoma with multiple lung metastases
A phase 2 study of cisplatin in patients with hepatocellular carcinoma
Okada S, Okazaki N, Nose H, et al : A phase 2 study of cisplatin in patients with hepatocellular carcinoma. Oncology 50;22-26:1993 (Pubitemid 23041107)
Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma: A Southeastern Cancer Study Group Trial
Ravry MJ, Omura GA, Bartolucci AA, et al : Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma : a Southeastern Cancer Study Group Trial. Cancer Treat Rep 70;311-312:1986
A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study
DOI 10.1002/1097-0142(19871101)60:9<2141::AID-CNCR2820600903>3.0. CO;2-4
Falkson G, Ryan LM, Johnson LA, et al : A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study. Cancer 60;2141-2145:1987 (Pubitemid 17153471)
Predictive factors for tumor response to systemic chemotherapy in patients with hepatocellular carcinoma
Nagahama H, Okada S, Okusaka T, et al : Predictive factors for tumor response to systemic chemotherapy in patients with hepatocellular carcinoma. Jpn J Clin Oncol 27;321-324:1997
Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma
DOI 10.1159/000076331
Ikeda M, Maeda S, Shibata J, et al : Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma. Oncology 66;24-31:2004 (Pubitemid 38410676)
Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma
Maeda S, Shibata J, Fujiyama S, et al : Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma. Hepatogastroenterology 50;809-813:2003